19:05 , Aug 11, 2017 |  BC Week In Review  |  Financial News

Biocept completes $2.2M private placement with Ally Bridge

Molecular diagnostic company Biocept Inc. (NASDAQ:BIOC) raised $2.2 million through the sale of 1.5 million shares at $1.50 in a private placement with Ally Bridge LB Healthcare Master Fund on Aug. 10. The fund also...
05:17 , Mar 31, 2017 |  BC Week In Review  |  Financial News

Biocept completes private placement

Molecular diagnostic company Biocept Inc. (NASDAQ:BIOC) raised $9.3 million through the sale of 4.3 million shares at $2.15 in a private placement with institutional investors on March 28. Investors also received five-year warrants to purchase...
01:06 , Feb 17, 2017 |  BC Innovations  |  Strategy

Putting genes to the test

As new technologies fill the landscape of molecular diagnostics, two fault lines are becoming clear: next-generation sequencing versus PCR, and tumor biopsies versus ctDNA. But while stakeholders believe there’s room for it all, they warn...
22:15 , Jan 6, 2017 |  BioCentury  |  Finance

Good riddance

  Investors aren’t lamenting the end of 2016, but they are pinned between anxiety and optimism for the year ahead. The anxiety stems from uncertainty about U.S. government policies for healthcare under the new administration....
07:00 , Oct 17, 2016 |  BC Week In Review  |  Financial News

Biocept completes follow-on

Biocept Inc. (NASDAQ:BIOC), San Diego, Calif.   Business: Diagnostic   Date completed: 2016-10-14   Type: Follow-on   Raised: $10 million   Shares: 9.1 million   Price: $1.10   Shares after offering: 17.5 million   Underwriters:...
07:00 , Oct 10, 2016 |  BC Week In Review  |  Financial News

Biocept amends follow-on

Biocept Inc. (NASDAQ:BIOC), San Diego, Calif.   Business: Diagnostic   Date announced: 2016-09-29   Type: Follow-on   To be raised: Up to $11 million   Shares: TBD   Price prior: $0.58   Underwriters: Roth Capital...
07:00 , Aug 22, 2016 |  BC Week In Review  |  Financial News

Biocept proposes follow-on

Biocept Inc. (NASDAQ:BIOC), San Diego, Calif.   Business: Diagnostic   Date announced: 2016-08-12   Type: Follow-on   To be raised: Up to $10 million   Shares: TBD   Price Prior: $0.58  ...
07:00 , Jun 6, 2016 |  BC Week In Review  |  Company News

Biocept sales and marketing update

Biocept launched an expression test for detecting and monitoring PD-L1 expression levels from circulating tumor cells (CTS) from blood samples. Biocept Inc. (NASDAQ:BIOC), San Diego, Calif.   Business: Diagnostic  ...
07:00 , May 9, 2016 |  BC Week In Review  |  Financial News

Biocept completes direct public offering

Biocept Inc. (NASDAQ:BIOC), San Diego, Calif.   Business: Diagnostic   Date completed: 2016-04-29   Type: Direct public offering   Raised: $5 million   Shares: 5 million   Price: $1   Shares after offering: 25 million...
08:00 , Mar 7, 2016 |  BC Week In Review  |  Company News

Biocept sales and marketing update

Biocept said U.S. healthcare PPO network Prime Health Services Inc. will cover Biocept’s liquid biopsy tests. Biocept said the deal expands the total number of covered lives to 140 million. Biocept’s liquid biopsy technology detects...